Form4insider filings, from the source

SEC Form 4 · accession 0001140361-18-022841

Emergent BioSolutions Inc. · EBS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Richard S Lindahl
Officer — EVP, Chief Financial Officer
Period of report
May 8, 2018
Accepted (ET)
May 10, 2018 · 5:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367644

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2May 8, 2018A4,992$0.00A4,992D
Common StockF1,F2May 8, 2018A1,551$0.00A6,543D
Common StockF3May 8, 2018A4,991$0.00A11,534D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (Right to Buy)F4$48.33May 8, 2018A19,963A—May 7, 2025Common Stock19,96319,963D

Explanation of responses